Xylem Analysts Lower Their Forecasts After Q4 Results

Benzinga

Feb 12

Xylem Inc (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.

The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.

Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.

“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”

Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.

These analysts made changes to their price targets on Xylem following earnings announcement.

Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.
RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.

Considering buying XYL stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610950767"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610950767\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610950767?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 02:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610950767","market":"us","top_or_hot":-1,"title":"Xylem Analysts Lower Their Forecasts After Q4 Results","media":"Benzinga","content":"<html><body><p><strong>Xylem Inc</strong> (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.</p>\n<p>The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.</p>\n<p>Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.</p>\n<p>“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”</p>\n<p>Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Xylem following earnings announcement.</p>\n<ul>\n<li>Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.</li>\n<li>RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.</li>\n</ul>\n<p><strong>Considering buying XYL stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"202\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-300x59.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-768x152.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229.png 1250w\" width=\"1024\"/></figure>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xylem Analysts Lower Their Forecasts After Q4 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXylem Analysts Lower Their Forecasts After Q4 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-02-12 02:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Xylem Inc</strong> (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.</p>\n<p>The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.</p>\n<p>Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.</p>\n<p>“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”</p>\n<p>Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Xylem following earnings announcement.</p>\n<ul>\n<li>Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.</li>\n<li>RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.</li>\n</ul>\n<p><strong>Considering buying XYL stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"202\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-300x59.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-768x152.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229.png 1250w\" width=\"1024\"/></figure>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2125910179.SGD","symbol_name":"Natixis Thematics Water H-R/A SGD","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50554299/xylem-analysts-lower-their-forecasts-after-q4-results","article_id":"2610950767","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610950767","pubTimestamp":1770834235,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","LU2413666004.HKD":"BNP PARIBAS AQUA \"CRH\" (HKDHDG) INC","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","LU2473716301.USD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMF\" (USD) INC","LU1543694498.USD":"法巴水资源基金RH MD Dis","LU1620156130.USD":"BNP PARIBAS AQUA \"C\" (USD) ACC","BK4588":"碎股","LU1620156213.USD":"BNP PARIBAS AQUA \"C\" (USD) INC","LU1992135472.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES \"AT\" (HKD) ACC","LU2308191902.HKD":"BNP PARIBAS ECOSYSTEM RESTORATION \"CLASSIC\" (HKD) ACC","LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","LU2298321311.HKD":"BGF CIRCULAR ECONOMY \"A\" (HKDHDG) ACC","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU2125910336.SGD":"Natixis Thematics Water R/A SGD","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU2272731865.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AM\" (HKD) INC","LU1923621640.USD":"Natixis Thematics Water R/A USD","LU2322448957.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMG\" (HKD) INC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","LU2089279066.USD":"ALLIANZ GLOBAL WATER \"AT\" (USD) ACC","LU2240825500.USD":"AZ EQUITY - WATER & RENEWABLE RESOURCES \"A-AZ\" (USD) ACC","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU2360108059.USD":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC","LU2322448791.USD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMG\" (USD) INC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU2229751404.USD":"ALLIANZ GLOBAL WATER \"AT3\" (USD) ACC","LU2272731600.USD":"Allianz Global Intelligent Cities AM Dis USD","BK4161":"工业机械","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU2041044095.USD":"Blackrock Circular Economy A2 USD","LU2092937221.SGD":"Blackrock Circular Economy A2 SGD-H","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","BK4585":"ETF&股票定投概念","LU1892829315.USD":"FIDELITY FUNDS SUSTAINABLE WATER & WASTE \"A\" (USD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1165135440.EUR":"BNP Paribas Aqua Classic Cap EUR","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","LU2394011477.USD":"JPMORGAN CLIMATE CHANGE SOLUTIONS \"A\" (USD) ACC","LU2413665964.HKD":"BNP PARIBAS AQUA \"C\" (HKD) ACC","LU2211814178.USD":"ALLIANZ CLEAN PLANET \"AT\" (USD) ACC","LU1721427968.SGD":"BNP PARIBAS AQUA \"CRH\" (SGDHDG) INC","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","XYL":"赛莱默","LU1596574779.USD":"BNP PARIBAS AQUA \"C\" (USDHDG) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD"},"translate_title":"赛莱默分析师在第四季度业绩公布后下调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XYL":1.5},"content_text":"Xylem Inc (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.\nThe company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.\nXylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.\n“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”\nXylem shares dipped 2.1% to trade at $126.24 on Wednesday.\nThese analysts made changes to their price targets on Xylem following earnings announcement.\n\nBarclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.\nRBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.\n\nConsidering buying XYL stock? Here’s what analysts think: \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}